Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Purpose We evaluated the efficacy of low-dose radiotherapy for painful shoulder syndrome from an orthopedic perspective. Methods Patients with painful shoulder syndrome were recruited for this retrospective clinical quality assessment from January 2011 to December 2017. Patients were treated with a linear accelerator or an orthovoltage device at individual doses of 0.5–1.0 Gy and total doses of 3.0–6.0 Gy. To assess response, we used the von Pannewitz score with five levels: “worsened,” “unaffected,” “improved,” “significantly improved,” and “symptom free.” “Good treatment success” was defined as “significantly improved” and “symptom free.” Within-group and between-group differences were statistically evaluated. Results Of 236 recruited patients (150 women, 86 men; mean age 66.3 [range 31–96] years), 180 patients underwent radiotherapy with a linear accelerator and 56 with an orthovoltage device. Fractionation was 12 × 0.5 Gy in 120 patients, 6 × 0.5 Gy in 74, and 6 × 1 Gy in 42 patients. Treatments were completed in one series for 223 and in two series at least 6 weeks apart for 13 patients. Of the 236 patients, 163 patients (69.1%) agreed to be re-interviewed at a median of 10.5 (range 4–60) months after radiotherapy completion. Directly after radiotherapy, 30.9% (73 patients) had “good treatment success,” which had increased to 55.2% (90 patients) at follow-up. Conclusion Protracted pain improvement with low-dose radiotherapy is possible in painful shoulder syndrome. Patients with refractory pain because of subacromial syndrome or shoulder osteoarthritis should also be evaluated for radiotherapy.
Purpose We evaluated the efficacy of low-dose radiotherapy for painful shoulder syndrome from an orthopedic perspective. Methods Patients with painful shoulder syndrome were recruited for this retrospective clinical quality assessment from January 2011 to December 2017. Patients were treated with a linear accelerator or an orthovoltage device at individual doses of 0.5–1.0 Gy and total doses of 3.0–6.0 Gy. To assess response, we used the von Pannewitz score with five levels: “worsened,” “unaffected,” “improved,” “significantly improved,” and “symptom free.” “Good treatment success” was defined as “significantly improved” and “symptom free.” Within-group and between-group differences were statistically evaluated. Results Of 236 recruited patients (150 women, 86 men; mean age 66.3 [range 31–96] years), 180 patients underwent radiotherapy with a linear accelerator and 56 with an orthovoltage device. Fractionation was 12 × 0.5 Gy in 120 patients, 6 × 0.5 Gy in 74, and 6 × 1 Gy in 42 patients. Treatments were completed in one series for 223 and in two series at least 6 weeks apart for 13 patients. Of the 236 patients, 163 patients (69.1%) agreed to be re-interviewed at a median of 10.5 (range 4–60) months after radiotherapy completion. Directly after radiotherapy, 30.9% (73 patients) had “good treatment success,” which had increased to 55.2% (90 patients) at follow-up. Conclusion Protracted pain improvement with low-dose radiotherapy is possible in painful shoulder syndrome. Patients with refractory pain because of subacromial syndrome or shoulder osteoarthritis should also be evaluated for radiotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.